The Lynx Group

    • Murray Aitken, MBA
    • Executive Director
    • IQVIA Institute
    • Brian Ansay
    • President, Specialty Physician GPOs
    • AmerisourceBergen
    • Roy Baynes, MD, PhD
    • Head, Global Clinical Development, Chief Medical Officer
    • Merck Research Laboratories
    • Al Benson, MD, FACP, FASCO
    • Professor or Medicine, Lurie Cancer Center
    • Northwestern University
    • Past Chair
    • NCCN
    • Mick Besse, MBA
    • President
    • Besse Medical, AmerisourceBergen
    • Linda Bosserman, MD, FASCO, FACP
    • Assistant Clinical Professor
    • City of Hope Medical Center
    • Roger Brito, DO
    • Division Head-Enterprise Oncology
    • CVS Health
    • Howard “Skip” Burris, III, MD, FACP, FASCO
    • President & Chief Medical Officer
    • Sarah Cannon
    • Rob Butcher
    • CEO
    • Swim Across America
    • Karen van Caulil, PhD
    • President & CEO
    • Florida Alliance for Healthcare Value
    • Kevan Corbett
    • VP/GM, GPO Services & Business Solutions
    • McKesson
    • David DeRemer, PharmD, BCOP, FCCP, FHOPA
    • Clinical Associate Professor & Assistant Director
    • Experimental Therapeutics
    • University of Florida Health Cancer Center
    • Michael Diaz, MD
    • Assistant Managing Physician & Vice President
    • Florida Cancer Specialists
    • Gabriela Dieguez, FSA, MAAA
    • Principal & Consulting Actuary
    • Milliman
    • Christian Downs, MHA, JD
    • Executive Director
    • Association of Community Cancer Centers
    • Andrea Dwyer, BS
    • Vice Chair
    • Colorado Cancer Coalition
    • Co-Chair, National Navigation Roundtable
    • American Cancer Society
    • Craig Eagle, MD
    • VP, Medical Affairs Oncology
    • Genentech
    • Bruce Feinberg, DO
    • Vice President and Chief Medical Officer
    • Cardinal Health Specialty Solutions
    • John Fox, MD
    • Associate Vice President of Medical Affairs
    • Priority Health
    • Elizabeth Franklin, PhD, MSW
    • Executive Director
    • Cancer Policy Institute
    • Co-Chair, Policy & Advocacy Committee
    • Academy of Oncology Nurse & Patient Navigators
    • Scott Freeswick, MS, PharmD
    • Vice President & CPO
    • Memorial Sloan Kettering Cancer Center
    • Marianne Gandee
    • Senior Director, Team Lead
    • Advocacy and Professional Relations
    • Pfizer Oncology
    • Michael Ganio, PharmD
    • Senior Director, Pharmacy Practice and Quality
    • ASHP
    • Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
    • Program Director
    • Academy of Oncology Nurse & Patient Navigators
    • Gerry Gleeson, MBA
    • VP & US Head of Market Access
    • Sandoz Inc.
    • Brian Gockerman, MBA
    • Managing Director
    • Unlimited Systems
    • Rena Goins
    • Executive Director
    • Global Trade, GPO & Distribution
    • Regeneron Healthcare Solutions, Inc.
    • Bob Gold
    • Chief Behavioral Technologist and CEO
    • GoMo Health
    • Patricia Goldsmith
    • CEO
    • CancerCare
    • Lucio Gordan, MD
    • President
    • Florida Cancer Specialists
    • Niesha Griffith, RPh, MS, FASHP
    • Chief Pharmacy Officer (Interim)
    • Naomi Gutierrez
    • Vice President
    • Account Management
    • McKesson
    • Mark Hagler, MBA
    • Senior Vice President Business Unit Head
    • US Oncology
    • Sun Pharma
    • Murray Harber
    • Executive Director
    • Mississippi Business Group on Health
    • Lisa Harrison, RPh
    • President
    • Oncology Supply, AmerisourceBergen
    • Arthur Hirt
    • Vice President
    • Oncology Commercial Operations, US Market
    • Merck
    • Ann Mond Johnson
    • CEO
    • ATA
    • Michael Joyner, MD
    • Professor
    • Mayo Clinic
    • Deborah Kamin, RN, PhD
    • Vice President
    • Policy and Advocacy
    • American Society of Clinical Oncology
    • Duane Kembel
    • National Vice President
    • Physician Office Sales
    • Cardinal Health
    • Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP, FAAN
    • Scientific & Clinical Affairs Liaison
    • Oncology Nursing Society
    • Karen Keown, RN
    • Co-Founder
    • Vida Healthcare
    • Daniel Klein
    • President & CEO
    • Patient Access Network Foundation
    • Michael Kolodziej, MD
    • Senior Advisor
    • ADVI Health
    • Timothy Kubal, MBA, MD
    • Senior Medical Director
    • Moffitt Cancer Center, Tampa
    • Rick Lee
    • Co-Founder
    • Quality Oncology, Value Health, Healthrageous, and MeYou Health
    • Brian Leyland-Jones, MD
    • Chief Medical Officer
    • National Center for Cancer Research
    • Bryan Loy, MD, MBA
    • Physician Lead, Oncology, Laboratory, and Personalized Medicine
    • Humana
    • Tom Lynch, MD
    • CEO & President
    • Fred Hutchinson Cancer Research Center
    • Barbara McAneny, MD, MACP, FASCO
    • CEO
    • New Mexico Oncology Hematology Consultants
    • Chris Marcum, PharmD
    • VP, Enterprise Pharmacy
    • Cancer Treatment Centers of America
    • Maurie Markman, MD
    • President, Medicine & Science
    • Cancer Treatment Centers of America
    • Ali McBride, PharmD, MBA
    • Clinical Coordinator
    • University of Arizona Cancer Center
    • Stacey McCullough, PharmD
    • SVP, Pharmacy
    • Tennessee Oncology, LLC
    • Brenda Nevidjon, MSN, RN, FAAN
    • CEO
    • Oncology Nursing Society
    • Lee Newcomer, MD
    • Former SVP
    • Oncology and Genetics
    • UnitedHealth Group
    • Principal
    • Lee N. Newcomer Consulting
    • Amy Niles
    • Executive Vice President
    • Patient Access Network Foundation
    • John O’Brien, PharmD, MPH
    • Former Senior Advisor to Secretary of US Department Health & Human Services
    • Kevin O’Hayer, MD, PhD
    • Senior Director
    • Immuno-Oncology
    • Incyte Corporation
    • Ted Okon, MBA
    • Executive Director
    • Community Oncology Alliance
    • Kashyap Patel, MD
    • CEO
    • Carolina Blood and Cancer Care Associates
    • Debra Patt, MD, PhD, MBA
    • Executive Vice President
    • Policy and Strategic Initiatives
    • Texas Oncology
    • Jeff Patton, MD
    • CEO
    • Tennessee Oncology
    • Pamela Pelizzari, MPH
    • Principal and Senior Healthcare Consultant
    • Milliman
    • Steven Peskin, MD, MBA, FACP
    • Executive Medical Director of Population Health and Transformation
    • Horizon BCBS
    • Bruce Pyenson, FSA, MAAA
    • Principal & Consulting Actuary
    • Milliman
    • Chevon Rariy, MD
    • Director, Telehealth
    • Cancer Treatment Centers of America
    • Julie Saba, MD, PhD
    • Professor of Pediatrics
    • UCSF
    • Richard Schilsky, MD, FACP, FSCT, FASCO
    • Executive Vice President and Chief Medical Officer
    • ASCO
    • Julian Schink, MD
    • Chief Medical Officer
    • Cancer Treatment Centers of America
    • Patrick Schmidt
    • CEO
    • FFF Enterprises
    • Bhavesh Shah, RPh, BCOP
    • Director of Specialty and Hematology/Oncology Pharmacy
    • Boston Medical Center
    • Nirav Shah, MBA
    • Head of Revenue Cycle Operations, Flatiron Health
    • Parag Shah
    • President, Practice Solutions
    • Integra Connect
    • Michael Sherman, MD, MBA, MS, SVP
    • Chief Medical Officer
    • Harvard Pilgrim Healthcare
    • Lillie Shockney, RN, BS, MAS, HON-ONN-CG
    • University Distinguished Service Professor of Breast Cancer
    • Professor of Surgery
    • Johns Hopkins University School of Medicine
    • Mark Sloan, MD
    • Associate Professor of Medicine
    • Boston University School of Medicine
    • Jayson Slotnik, JD, MPH
    • Managing Partner
    • Health Policy Strategies
    • Art Taft
    • Managing Director
    • Medworks
    • Amy Valley, PharmD
    • Vice President
    • Clinical Strategy and Technology Solutions
    • Cardinal Health Specialty Solutions
    • Randy Vogenberg, PhD
    • Board Chair
    • Employer-Provider Interface Council [EPIC] of the HQF
    • Principal
    • Institute for Integrated Healthcare
    • Sally Werner, RN, BSN, MSHA
    • Executive Director
    • Institute for Excellence in Psychosocial Care
    • Cancer Support Community
    • Bruce Wilson
    • Head
    • Access Strategy
    • US Oncology
    • AstraZeneca
    • Jedd Wolchok, MD, PhD, FASCO
    • Chief
    • Immuno-Oncology
    • Memorial Sloan Kettering Cancer Center
    • Bryon Wornson
    • VP, Oncology Patient and Health Impact Lead
    • Pfizer
    • Burt Zweigenhaft, PhD, D.Litt
    • Founder & Co-Chair
    • AVBCC

Personalized Medicine | Browse By Specialty

We Want to Know

Is access to care an obstacle for patients today?


Latest Videos

Telehealth & Oncology During the Fight Against COVID-19 and Its Aftermath
Using FGFR Inhibitors in Clinical Practice

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: